GH-releasing peptide (GHRP-6)-induced ACTH release in patients with Addison’s disease: Effect of glucocorticoid withdrawal - Martins, Manoel Ricardo Alves; Pinto, A-C. A. R.; Brunner, E.; Silva, M. R. D.; Lengyel, A-M. J. (Journal of endocrinological investigation, 2003)
Keywords: Addison Disease - drug therapy; Addison Disease - metabolism; Adrenals. Adrenal axis. Renin-angiotensin system (diseases); Adrenocorticotropic Hormone - blood; Adrenocorticotropic Hormone - secretion; Adult; Biological and medical sciences; Endocrinopathies; Female; Glucocorticoids - therapeutic use; Humans; Hydrocortisone - blood; Hypothalamo-Hypophyseal System - drug effects; Male; Medical sciences; Middle Aged; Non tumoral diseases. Target tissue resistance. Benign neoplasms; Oligopeptides - pharmacology; Oligopeptides - therapeutic use; Pituitary-Adrenal System - drug effects; Prednisone - therapeutic use; Endocrinopathy; Human; Replacement therapy; Addison disease; Adrenal cortex diseases; Steroid hormone; Peptide hormone; Glucocorticoid; Adrenal insufficiency; Adrenocorticotropic hormone; Adenohypophyseal hormone; Hypocorticism; Adrenal hormone; Adrenal gland diseases; Hormone replacement therapy; Comparative study; Hypothalamohypophysocorticoadrenal axis; Provocation test